Penn Hematology/Oncology investigators continue to publish high profile and important findings in diverse fields, ranging from the most fundamental cellular investigations, to the most leading edge translational and clinical research.
There are 25 faculty members in the Penn Hematology/Oncology Division who are engaged in full-time laboratory research. These investigators continue to publish high profile and important findings in diverse fields, ranging from the most fundamental cellular investigations, to the most cutting-edge translational and clinical research.
The focus of the basic science research in hematology and medical oncology includes:
- Platelet biology
- Cancer biology
- Cancer immunobiology
- Cancer stem cells
- HIV/host blood cell interactions
Faculty members are the principal investigators for a number of grants from the National Institutes of Health (NIH) and other institutions. These include RO1s, R21s, Leukemia and Lymphoma Society Grants, ASH Scholar Grants, P50s, U54s, Centers for Disease Control Funding, and Maternal, and Child Health Bureau Funding. In addition to individual grants, hematology and medical oncology lead PO1s in platelet biology, thrombosis, and immune therapeutics.
Penn Hematology/Oncology has several laboratories on the University of Pennsylvania and Children's Hospital of Philadelphia (CHOP) campuses.